• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX
Click for more information
16.7% 0.5¢

INVION LIMITED - Charts / Financials

Market Cap $32.12M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Invion Limited is an Australia-based life sciences company. The Company is engaged in the... Invion Limited is an Australia-based life sciences company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 14.46pm 03/05/2024 (20 minute delay) ?
Day
Open 0.5¢   Day High 0.5¢   Day Low 0.5¢
Daily Volume 3056860
Bids   Sellers
Number Price Volume   Number Price Volume
4 0.5¢ 880901   13 0.6¢ 7143246

Directors & Senior Management

Mr. Thian C. Chew Executive Chairman of the Board, Chief Executive Officer
Ms. Melanie Leydin Chief Financial Officer
Ms. Claire Newstead-Sinclair Company Secretary
Mr. Alistair Bennallack Non-Executive Director
Mr. Robert Merriel Non-Executive Director
Mr. Alan Yamashita Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
0.5¢ 		Change
-0.001(16.7%) 		Mkt cap ! $32.12M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $15.28K 3.056M

Buyers (Bids)

No. Vol. Price($)
4 880901 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 7143246 13
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
-0.001 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 971625
Last updated 14.46pm 03/05/2024 ?

Top Stories

Patagonia shares rise above 20% on lithium grades at maiden well in Argentina

Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at the first drill well of its Argentinian Formentera Lithium Project.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Infini Resources gearing up for UAV geophys survey over Portland Creek Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Group Ltd (ASX:MQG) has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green in...
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.